Global ADC Drug CDMO Service Market Growth (Status and Outlook) 2026-2032
The global ADC Drug CDMO Service market size is predicted to grow from US$ 3316 million in 2025 to US$ 11430 million in 2032; it is expected to grow at a CAGR of 19.7% from 2026 to 2032.
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.
The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.
LPI (LP Information)' newest research report, the “ADC Drug CDMO Service Industry Forecast” looks at past sales and reviews total world ADC Drug CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected ADC Drug CDMO Service sales for 2026 through 2032. With ADC Drug CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADC Drug CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global ADC Drug CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ADC Drug CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ADC Drug CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADC Drug CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADC Drug CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of ADC Drug CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.
The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.
LPI (LP Information)' newest research report, the “ADC Drug CDMO Service Industry Forecast” looks at past sales and reviews total world ADC Drug CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected ADC Drug CDMO Service sales for 2026 through 2032. With ADC Drug CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADC Drug CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global ADC Drug CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ADC Drug CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ADC Drug CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADC Drug CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADC Drug CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of ADC Drug CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cleavable Linkers
- Non-cleavable Linkers
- Small and Medium-sized Pharmaceutical Companies
- Large Pharmaceutical Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza Group
- Merck KGaA
- WuXi XDC
- Abbvie
- Piramal Pharma Solutions
- Catalent
- Sterling Pharma Solutions
- Axplora
- Aji Bio-Pharma
- BSP Pharmaceuticals
- Cerbios-Pharma
- Goodwin Biotechnology
- TOT Biopharm
- Huadong Medicine
- Innovent Biologics
- Shanghai Henlius Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ADC Drug CDMO Service Market Size (2021-2032)
2.1.2 ADC Drug CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for ADC Drug CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 ADC Drug CDMO Service Segment by Type
2.2.1 Cleavable Linkers
2.2.2 Non-cleavable Linkers
2.2.3 ADC Drug CDMO Service Market Size by Type
2.2.3.1 ADC Drug CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
2.3 ADC Drug CDMO Service Segment by Application
2.3.1 Small and Medium-sized Pharmaceutical Companies
2.3.2 Large Pharmaceutical Companies
2.3.3 ADC Drug CDMO Service Market Size by Application
2.3.3.1 ADC Drug CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
3 ADC DRUG CDMO SERVICE MARKET SIZE BY PLAYER
3.1 ADC Drug CDMO Service Market Size Market Share by Player
3.1.1 Global ADC Drug CDMO Service Revenue by Player (2021-2026)
3.1.2 Global ADC Drug CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global ADC Drug CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADC DRUG CDMO SERVICE BY REGION
4.1 ADC Drug CDMO Service Market Size by Region (2021-2026)
4.2 Global ADC Drug CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas ADC Drug CDMO Service Market Size Growth (2021-2026)
4.4 APAC ADC Drug CDMO Service Market Size Growth (2021-2026)
4.5 Europe ADC Drug CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa ADC Drug CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas ADC Drug CDMO Service Market Size by Country (2021-2026)
5.2 Americas ADC Drug CDMO Service Market Size by Type (2021-2026)
5.3 Americas ADC Drug CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ADC Drug CDMO Service Market Size by Region (2021-2026)
6.2 APAC ADC Drug CDMO Service Market Size by Type (2021-2026)
6.3 APAC ADC Drug CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ADC Drug CDMO Service Market Size by Country (2021-2026)
7.2 Europe ADC Drug CDMO Service Market Size by Type (2021-2026)
7.3 Europe ADC Drug CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ADC Drug CDMO Service by Region (2021-2026)
8.2 Middle East & Africa ADC Drug CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa ADC Drug CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADC DRUG CDMO SERVICE MARKET FORECAST
10.1 Global ADC Drug CDMO Service Forecast by Region (2027-2032)
10.1.1 Global ADC Drug CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas ADC Drug CDMO Service Forecast
10.1.3 APAC ADC Drug CDMO Service Forecast
10.1.4 Europe ADC Drug CDMO Service Forecast
10.1.5 Middle East & Africa ADC Drug CDMO Service Forecast
10.2 Americas ADC Drug CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market ADC Drug CDMO Service Forecast
10.2.2 Canada Market ADC Drug CDMO Service Forecast
10.2.3 Mexico Market ADC Drug CDMO Service Forecast
10.2.4 Brazil Market ADC Drug CDMO Service Forecast
10.3 APAC ADC Drug CDMO Service Forecast by Region (2027-2032)
10.3.1 China ADC Drug CDMO Service Market Forecast
10.3.2 Japan Market ADC Drug CDMO Service Forecast
10.3.3 Korea Market ADC Drug CDMO Service Forecast
10.3.4 Southeast Asia Market ADC Drug CDMO Service Forecast
10.3.5 India Market ADC Drug CDMO Service Forecast
10.3.6 Australia Market ADC Drug CDMO Service Forecast
10.4 Europe ADC Drug CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market ADC Drug CDMO Service Forecast
10.4.2 France Market ADC Drug CDMO Service Forecast
10.4.3 UK Market ADC Drug CDMO Service Forecast
10.4.4 Italy Market ADC Drug CDMO Service Forecast
10.4.5 Russia Market ADC Drug CDMO Service Forecast
10.5 Middle East & Africa ADC Drug CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market ADC Drug CDMO Service Forecast
10.5.2 South Africa Market ADC Drug CDMO Service Forecast
10.5.3 Israel Market ADC Drug CDMO Service Forecast
10.5.4 Turkey Market ADC Drug CDMO Service Forecast
10.6 Global ADC Drug CDMO Service Forecast by Type (2027-2032)
10.7 Global ADC Drug CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market ADC Drug CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group ADC Drug CDMO Service Product Offered
11.1.3 Lonza Group ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA ADC Drug CDMO Service Product Offered
11.2.3 Merck KGaA ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 WuXi XDC
11.3.1 WuXi XDC Company Information
11.3.2 WuXi XDC ADC Drug CDMO Service Product Offered
11.3.3 WuXi XDC ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 WuXi XDC Main Business Overview
11.3.5 WuXi XDC Latest Developments
11.4 Abbvie
11.4.1 Abbvie Company Information
11.4.2 Abbvie ADC Drug CDMO Service Product Offered
11.4.3 Abbvie ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Abbvie Main Business Overview
11.4.5 Abbvie Latest Developments
11.5 Piramal Pharma Solutions
11.5.1 Piramal Pharma Solutions Company Information
11.5.2 Piramal Pharma Solutions ADC Drug CDMO Service Product Offered
11.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Piramal Pharma Solutions Main Business Overview
11.5.5 Piramal Pharma Solutions Latest Developments
11.6 Catalent
11.6.1 Catalent Company Information
11.6.2 Catalent ADC Drug CDMO Service Product Offered
11.6.3 Catalent ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Catalent Main Business Overview
11.6.5 Catalent Latest Developments
11.7 Sterling Pharma Solutions
11.7.1 Sterling Pharma Solutions Company Information
11.7.2 Sterling Pharma Solutions ADC Drug CDMO Service Product Offered
11.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sterling Pharma Solutions Main Business Overview
11.7.5 Sterling Pharma Solutions Latest Developments
11.8 Axplora
11.8.1 Axplora Company Information
11.8.2 Axplora ADC Drug CDMO Service Product Offered
11.8.3 Axplora ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Axplora Main Business Overview
11.8.5 Axplora Latest Developments
11.9 Aji Bio-Pharma
11.9.1 Aji Bio-Pharma Company Information
11.9.2 Aji Bio-Pharma ADC Drug CDMO Service Product Offered
11.9.3 Aji Bio-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aji Bio-Pharma Main Business Overview
11.9.5 Aji Bio-Pharma Latest Developments
11.10 BSP Pharmaceuticals
11.10.1 BSP Pharmaceuticals Company Information
11.10.2 BSP Pharmaceuticals ADC Drug CDMO Service Product Offered
11.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BSP Pharmaceuticals Main Business Overview
11.10.5 BSP Pharmaceuticals Latest Developments
11.11 Cerbios-Pharma
11.11.1 Cerbios-Pharma Company Information
11.11.2 Cerbios-Pharma ADC Drug CDMO Service Product Offered
11.11.3 Cerbios-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cerbios-Pharma Main Business Overview
11.11.5 Cerbios-Pharma Latest Developments
11.12 Goodwin Biotechnology
11.12.1 Goodwin Biotechnology Company Information
11.12.2 Goodwin Biotechnology ADC Drug CDMO Service Product Offered
11.12.3 Goodwin Biotechnology ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Goodwin Biotechnology Main Business Overview
11.12.5 Goodwin Biotechnology Latest Developments
11.13 TOT Biopharm
11.13.1 TOT Biopharm Company Information
11.13.2 TOT Biopharm ADC Drug CDMO Service Product Offered
11.13.3 TOT Biopharm ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 TOT Biopharm Main Business Overview
11.13.5 TOT Biopharm Latest Developments
11.14 Huadong Medicine
11.14.1 Huadong Medicine Company Information
11.14.2 Huadong Medicine ADC Drug CDMO Service Product Offered
11.14.3 Huadong Medicine ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Huadong Medicine Main Business Overview
11.14.5 Huadong Medicine Latest Developments
11.15 Innovent Biologics
11.15.1 Innovent Biologics Company Information
11.15.2 Innovent Biologics ADC Drug CDMO Service Product Offered
11.15.3 Innovent Biologics ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Innovent Biologics Main Business Overview
11.15.5 Innovent Biologics Latest Developments
11.16 Shanghai Henlius Biotech
11.16.1 Shanghai Henlius Biotech Company Information
11.16.2 Shanghai Henlius Biotech ADC Drug CDMO Service Product Offered
11.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Shanghai Henlius Biotech Main Business Overview
11.16.5 Shanghai Henlius Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ADC Drug CDMO Service Market Size (2021-2032)
2.1.2 ADC Drug CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for ADC Drug CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 ADC Drug CDMO Service Segment by Type
2.2.1 Cleavable Linkers
2.2.2 Non-cleavable Linkers
2.2.3 ADC Drug CDMO Service Market Size by Type
2.2.3.1 ADC Drug CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
2.3 ADC Drug CDMO Service Segment by Application
2.3.1 Small and Medium-sized Pharmaceutical Companies
2.3.2 Large Pharmaceutical Companies
2.3.3 ADC Drug CDMO Service Market Size by Application
2.3.3.1 ADC Drug CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
3 ADC DRUG CDMO SERVICE MARKET SIZE BY PLAYER
3.1 ADC Drug CDMO Service Market Size Market Share by Player
3.1.1 Global ADC Drug CDMO Service Revenue by Player (2021-2026)
3.1.2 Global ADC Drug CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global ADC Drug CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADC DRUG CDMO SERVICE BY REGION
4.1 ADC Drug CDMO Service Market Size by Region (2021-2026)
4.2 Global ADC Drug CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas ADC Drug CDMO Service Market Size Growth (2021-2026)
4.4 APAC ADC Drug CDMO Service Market Size Growth (2021-2026)
4.5 Europe ADC Drug CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa ADC Drug CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas ADC Drug CDMO Service Market Size by Country (2021-2026)
5.2 Americas ADC Drug CDMO Service Market Size by Type (2021-2026)
5.3 Americas ADC Drug CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ADC Drug CDMO Service Market Size by Region (2021-2026)
6.2 APAC ADC Drug CDMO Service Market Size by Type (2021-2026)
6.3 APAC ADC Drug CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ADC Drug CDMO Service Market Size by Country (2021-2026)
7.2 Europe ADC Drug CDMO Service Market Size by Type (2021-2026)
7.3 Europe ADC Drug CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ADC Drug CDMO Service by Region (2021-2026)
8.2 Middle East & Africa ADC Drug CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa ADC Drug CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADC DRUG CDMO SERVICE MARKET FORECAST
10.1 Global ADC Drug CDMO Service Forecast by Region (2027-2032)
10.1.1 Global ADC Drug CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas ADC Drug CDMO Service Forecast
10.1.3 APAC ADC Drug CDMO Service Forecast
10.1.4 Europe ADC Drug CDMO Service Forecast
10.1.5 Middle East & Africa ADC Drug CDMO Service Forecast
10.2 Americas ADC Drug CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market ADC Drug CDMO Service Forecast
10.2.2 Canada Market ADC Drug CDMO Service Forecast
10.2.3 Mexico Market ADC Drug CDMO Service Forecast
10.2.4 Brazil Market ADC Drug CDMO Service Forecast
10.3 APAC ADC Drug CDMO Service Forecast by Region (2027-2032)
10.3.1 China ADC Drug CDMO Service Market Forecast
10.3.2 Japan Market ADC Drug CDMO Service Forecast
10.3.3 Korea Market ADC Drug CDMO Service Forecast
10.3.4 Southeast Asia Market ADC Drug CDMO Service Forecast
10.3.5 India Market ADC Drug CDMO Service Forecast
10.3.6 Australia Market ADC Drug CDMO Service Forecast
10.4 Europe ADC Drug CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market ADC Drug CDMO Service Forecast
10.4.2 France Market ADC Drug CDMO Service Forecast
10.4.3 UK Market ADC Drug CDMO Service Forecast
10.4.4 Italy Market ADC Drug CDMO Service Forecast
10.4.5 Russia Market ADC Drug CDMO Service Forecast
10.5 Middle East & Africa ADC Drug CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market ADC Drug CDMO Service Forecast
10.5.2 South Africa Market ADC Drug CDMO Service Forecast
10.5.3 Israel Market ADC Drug CDMO Service Forecast
10.5.4 Turkey Market ADC Drug CDMO Service Forecast
10.6 Global ADC Drug CDMO Service Forecast by Type (2027-2032)
10.7 Global ADC Drug CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market ADC Drug CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group ADC Drug CDMO Service Product Offered
11.1.3 Lonza Group ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA ADC Drug CDMO Service Product Offered
11.2.3 Merck KGaA ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 WuXi XDC
11.3.1 WuXi XDC Company Information
11.3.2 WuXi XDC ADC Drug CDMO Service Product Offered
11.3.3 WuXi XDC ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 WuXi XDC Main Business Overview
11.3.5 WuXi XDC Latest Developments
11.4 Abbvie
11.4.1 Abbvie Company Information
11.4.2 Abbvie ADC Drug CDMO Service Product Offered
11.4.3 Abbvie ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Abbvie Main Business Overview
11.4.5 Abbvie Latest Developments
11.5 Piramal Pharma Solutions
11.5.1 Piramal Pharma Solutions Company Information
11.5.2 Piramal Pharma Solutions ADC Drug CDMO Service Product Offered
11.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Piramal Pharma Solutions Main Business Overview
11.5.5 Piramal Pharma Solutions Latest Developments
11.6 Catalent
11.6.1 Catalent Company Information
11.6.2 Catalent ADC Drug CDMO Service Product Offered
11.6.3 Catalent ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Catalent Main Business Overview
11.6.5 Catalent Latest Developments
11.7 Sterling Pharma Solutions
11.7.1 Sterling Pharma Solutions Company Information
11.7.2 Sterling Pharma Solutions ADC Drug CDMO Service Product Offered
11.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sterling Pharma Solutions Main Business Overview
11.7.5 Sterling Pharma Solutions Latest Developments
11.8 Axplora
11.8.1 Axplora Company Information
11.8.2 Axplora ADC Drug CDMO Service Product Offered
11.8.3 Axplora ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Axplora Main Business Overview
11.8.5 Axplora Latest Developments
11.9 Aji Bio-Pharma
11.9.1 Aji Bio-Pharma Company Information
11.9.2 Aji Bio-Pharma ADC Drug CDMO Service Product Offered
11.9.3 Aji Bio-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aji Bio-Pharma Main Business Overview
11.9.5 Aji Bio-Pharma Latest Developments
11.10 BSP Pharmaceuticals
11.10.1 BSP Pharmaceuticals Company Information
11.10.2 BSP Pharmaceuticals ADC Drug CDMO Service Product Offered
11.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BSP Pharmaceuticals Main Business Overview
11.10.5 BSP Pharmaceuticals Latest Developments
11.11 Cerbios-Pharma
11.11.1 Cerbios-Pharma Company Information
11.11.2 Cerbios-Pharma ADC Drug CDMO Service Product Offered
11.11.3 Cerbios-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cerbios-Pharma Main Business Overview
11.11.5 Cerbios-Pharma Latest Developments
11.12 Goodwin Biotechnology
11.12.1 Goodwin Biotechnology Company Information
11.12.2 Goodwin Biotechnology ADC Drug CDMO Service Product Offered
11.12.3 Goodwin Biotechnology ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Goodwin Biotechnology Main Business Overview
11.12.5 Goodwin Biotechnology Latest Developments
11.13 TOT Biopharm
11.13.1 TOT Biopharm Company Information
11.13.2 TOT Biopharm ADC Drug CDMO Service Product Offered
11.13.3 TOT Biopharm ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 TOT Biopharm Main Business Overview
11.13.5 TOT Biopharm Latest Developments
11.14 Huadong Medicine
11.14.1 Huadong Medicine Company Information
11.14.2 Huadong Medicine ADC Drug CDMO Service Product Offered
11.14.3 Huadong Medicine ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Huadong Medicine Main Business Overview
11.14.5 Huadong Medicine Latest Developments
11.15 Innovent Biologics
11.15.1 Innovent Biologics Company Information
11.15.2 Innovent Biologics ADC Drug CDMO Service Product Offered
11.15.3 Innovent Biologics ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Innovent Biologics Main Business Overview
11.15.5 Innovent Biologics Latest Developments
11.16 Shanghai Henlius Biotech
11.16.1 Shanghai Henlius Biotech Company Information
11.16.2 Shanghai Henlius Biotech ADC Drug CDMO Service Product Offered
11.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Shanghai Henlius Biotech Main Business Overview
11.16.5 Shanghai Henlius Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. ADC Drug CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. ADC Drug CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cleavable Linkers
Table 4. Major Players of Non-cleavable Linkers
Table 5. ADC Drug CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Table 8. ADC Drug CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Table 11. Global ADC Drug CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global ADC Drug CDMO Service Revenue Market Share by Player (2021-2026)
Table 13. ADC Drug CDMO Service Key Players Head office and Products Offered
Table 14. ADC Drug CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Table 19. Global ADC Drug CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global ADC Drug CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas ADC Drug CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas ADC Drug CDMO Service Market Size Market Share by Country (2021-2026)
Table 23. Americas ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Table 25. Americas ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Table 27. APAC ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Table 29. APAC ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe ADC Drug CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe ADC Drug CDMO Service Market Size Market Share by Country (2021-2026)
Table 33. Europe ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of ADC Drug CDMO Service
Table 39. Key Market Challenges & Risks of ADC Drug CDMO Service
Table 40. Key Industry Trends of ADC Drug CDMO Service
Table 41. Global ADC Drug CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global ADC Drug CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global ADC Drug CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global ADC Drug CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lonza Group Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 46. Lonza Group ADC Drug CDMO Service Product Offered
Table 47. Lonza Group ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lonza Group Main Business
Table 49. Lonza Group Latest Developments
Table 50. Merck KGaA Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 51. Merck KGaA ADC Drug CDMO Service Product Offered
Table 52. Merck KGaA ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Merck KGaA Main Business
Table 54. Merck KGaA Latest Developments
Table 55. WuXi XDC Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 56. WuXi XDC ADC Drug CDMO Service Product Offered
Table 57. WuXi XDC ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. WuXi XDC Main Business
Table 59. WuXi XDC Latest Developments
Table 60. Abbvie Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 61. Abbvie ADC Drug CDMO Service Product Offered
Table 62. Abbvie ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Abbvie Main Business
Table 64. Abbvie Latest Developments
Table 65. Piramal Pharma Solutions Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 66. Piramal Pharma Solutions ADC Drug CDMO Service Product Offered
Table 67. Piramal Pharma Solutions ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Piramal Pharma Solutions Main Business
Table 69. Piramal Pharma Solutions Latest Developments
Table 70. Catalent Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 71. Catalent ADC Drug CDMO Service Product Offered
Table 72. Catalent ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Catalent Main Business
Table 74. Catalent Latest Developments
Table 75. Sterling Pharma Solutions Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 76. Sterling Pharma Solutions ADC Drug CDMO Service Product Offered
Table 77. Sterling Pharma Solutions ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Sterling Pharma Solutions Main Business
Table 79. Sterling Pharma Solutions Latest Developments
Table 80. Axplora Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 81. Axplora ADC Drug CDMO Service Product Offered
Table 82. Axplora ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Axplora Main Business
Table 84. Axplora Latest Developments
Table 85. Aji Bio-Pharma Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 86. Aji Bio-Pharma ADC Drug CDMO Service Product Offered
Table 87. Aji Bio-Pharma ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Aji Bio-Pharma Main Business
Table 89. Aji Bio-Pharma Latest Developments
Table 90. BSP Pharmaceuticals Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 91. BSP Pharmaceuticals ADC Drug CDMO Service Product Offered
Table 92. BSP Pharmaceuticals ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. BSP Pharmaceuticals Main Business
Table 94. BSP Pharmaceuticals Latest Developments
Table 95. Cerbios-Pharma Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 96. Cerbios-Pharma ADC Drug CDMO Service Product Offered
Table 97. Cerbios-Pharma ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Cerbios-Pharma Main Business
Table 99. Cerbios-Pharma Latest Developments
Table 100. Goodwin Biotechnology Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 101. Goodwin Biotechnology ADC Drug CDMO Service Product Offered
Table 102. Goodwin Biotechnology ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Goodwin Biotechnology Main Business
Table 104. Goodwin Biotechnology Latest Developments
Table 105. TOT Biopharm Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 106. TOT Biopharm ADC Drug CDMO Service Product Offered
Table 107. TOT Biopharm ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. TOT Biopharm Main Business
Table 109. TOT Biopharm Latest Developments
Table 110. Huadong Medicine Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 111. Huadong Medicine ADC Drug CDMO Service Product Offered
Table 112. Huadong Medicine ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Huadong Medicine Main Business
Table 114. Huadong Medicine Latest Developments
Table 115. Innovent Biologics Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 116. Innovent Biologics ADC Drug CDMO Service Product Offered
Table 117. Innovent Biologics ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Innovent Biologics Main Business
Table 119. Innovent Biologics Latest Developments
Table 120. Shanghai Henlius Biotech Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 121. Shanghai Henlius Biotech ADC Drug CDMO Service Product Offered
Table 122. Shanghai Henlius Biotech ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Shanghai Henlius Biotech Main Business
Table 124. Shanghai Henlius Biotech Latest Developments
Table 1. ADC Drug CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. ADC Drug CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cleavable Linkers
Table 4. Major Players of Non-cleavable Linkers
Table 5. ADC Drug CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Table 8. ADC Drug CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Table 11. Global ADC Drug CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global ADC Drug CDMO Service Revenue Market Share by Player (2021-2026)
Table 13. ADC Drug CDMO Service Key Players Head office and Products Offered
Table 14. ADC Drug CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Table 19. Global ADC Drug CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global ADC Drug CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas ADC Drug CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas ADC Drug CDMO Service Market Size Market Share by Country (2021-2026)
Table 23. Americas ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Table 25. Americas ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Table 27. APAC ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Table 29. APAC ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe ADC Drug CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe ADC Drug CDMO Service Market Size Market Share by Country (2021-2026)
Table 33. Europe ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa ADC Drug CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa ADC Drug CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa ADC Drug CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of ADC Drug CDMO Service
Table 39. Key Market Challenges & Risks of ADC Drug CDMO Service
Table 40. Key Industry Trends of ADC Drug CDMO Service
Table 41. Global ADC Drug CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global ADC Drug CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global ADC Drug CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global ADC Drug CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lonza Group Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 46. Lonza Group ADC Drug CDMO Service Product Offered
Table 47. Lonza Group ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lonza Group Main Business
Table 49. Lonza Group Latest Developments
Table 50. Merck KGaA Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 51. Merck KGaA ADC Drug CDMO Service Product Offered
Table 52. Merck KGaA ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Merck KGaA Main Business
Table 54. Merck KGaA Latest Developments
Table 55. WuXi XDC Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 56. WuXi XDC ADC Drug CDMO Service Product Offered
Table 57. WuXi XDC ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. WuXi XDC Main Business
Table 59. WuXi XDC Latest Developments
Table 60. Abbvie Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 61. Abbvie ADC Drug CDMO Service Product Offered
Table 62. Abbvie ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Abbvie Main Business
Table 64. Abbvie Latest Developments
Table 65. Piramal Pharma Solutions Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 66. Piramal Pharma Solutions ADC Drug CDMO Service Product Offered
Table 67. Piramal Pharma Solutions ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Piramal Pharma Solutions Main Business
Table 69. Piramal Pharma Solutions Latest Developments
Table 70. Catalent Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 71. Catalent ADC Drug CDMO Service Product Offered
Table 72. Catalent ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Catalent Main Business
Table 74. Catalent Latest Developments
Table 75. Sterling Pharma Solutions Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 76. Sterling Pharma Solutions ADC Drug CDMO Service Product Offered
Table 77. Sterling Pharma Solutions ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Sterling Pharma Solutions Main Business
Table 79. Sterling Pharma Solutions Latest Developments
Table 80. Axplora Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 81. Axplora ADC Drug CDMO Service Product Offered
Table 82. Axplora ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Axplora Main Business
Table 84. Axplora Latest Developments
Table 85. Aji Bio-Pharma Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 86. Aji Bio-Pharma ADC Drug CDMO Service Product Offered
Table 87. Aji Bio-Pharma ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Aji Bio-Pharma Main Business
Table 89. Aji Bio-Pharma Latest Developments
Table 90. BSP Pharmaceuticals Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 91. BSP Pharmaceuticals ADC Drug CDMO Service Product Offered
Table 92. BSP Pharmaceuticals ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. BSP Pharmaceuticals Main Business
Table 94. BSP Pharmaceuticals Latest Developments
Table 95. Cerbios-Pharma Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 96. Cerbios-Pharma ADC Drug CDMO Service Product Offered
Table 97. Cerbios-Pharma ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Cerbios-Pharma Main Business
Table 99. Cerbios-Pharma Latest Developments
Table 100. Goodwin Biotechnology Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 101. Goodwin Biotechnology ADC Drug CDMO Service Product Offered
Table 102. Goodwin Biotechnology ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Goodwin Biotechnology Main Business
Table 104. Goodwin Biotechnology Latest Developments
Table 105. TOT Biopharm Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 106. TOT Biopharm ADC Drug CDMO Service Product Offered
Table 107. TOT Biopharm ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. TOT Biopharm Main Business
Table 109. TOT Biopharm Latest Developments
Table 110. Huadong Medicine Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 111. Huadong Medicine ADC Drug CDMO Service Product Offered
Table 112. Huadong Medicine ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Huadong Medicine Main Business
Table 114. Huadong Medicine Latest Developments
Table 115. Innovent Biologics Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 116. Innovent Biologics ADC Drug CDMO Service Product Offered
Table 117. Innovent Biologics ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Innovent Biologics Main Business
Table 119. Innovent Biologics Latest Developments
Table 120. Shanghai Henlius Biotech Details, Company Type, ADC Drug CDMO Service Area Served and Its Competitors
Table 121. Shanghai Henlius Biotech ADC Drug CDMO Service Product Offered
Table 122. Shanghai Henlius Biotech ADC Drug CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Shanghai Henlius Biotech Main Business
Table 124. Shanghai Henlius Biotech Latest Developments
LIST OF FIGURES
Figure 1. ADC Drug CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ADC Drug CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. ADC Drug CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. ADC Drug CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. ADC Drug CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global ADC Drug CDMO Service Market Size Market Share by Type in 2025
Figure 10. ADC Drug CDMO Service in Small and Medium-sized Pharmaceutical Companies
Figure 11. Global ADC Drug CDMO Service Market: Small and Medium-sized Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. ADC Drug CDMO Service in Large Pharmaceutical Companies
Figure 13. Global ADC Drug CDMO Service Market: Large Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Global ADC Drug CDMO Service Market Size Market Share by Application in 2025
Figure 15. Global ADC Drug CDMO Service Revenue Market Share by Player in 2025
Figure 16. Global ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 18. APAC ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 19. Europe ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 21. Americas ADC Drug CDMO Service Value Market Share by Country in 2025
Figure 22. United States ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC ADC Drug CDMO Service Market Size Market Share by Region in 2025
Figure 27. APAC ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 29. China ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe ADC Drug CDMO Service Market Size Market Share by Country in 2025
Figure 36. Europe ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 52. APAC ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 53. Europe ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 55. United States ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. Canada ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. China ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Japan ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Korea ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. India ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Australia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Germany ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. France ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. UK ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Italy ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Russia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Israel ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Global ADC Drug CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global ADC Drug CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 1. ADC Drug CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ADC Drug CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. ADC Drug CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. ADC Drug CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. ADC Drug CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global ADC Drug CDMO Service Market Size Market Share by Type in 2025
Figure 10. ADC Drug CDMO Service in Small and Medium-sized Pharmaceutical Companies
Figure 11. Global ADC Drug CDMO Service Market: Small and Medium-sized Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. ADC Drug CDMO Service in Large Pharmaceutical Companies
Figure 13. Global ADC Drug CDMO Service Market: Large Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Global ADC Drug CDMO Service Market Size Market Share by Application in 2025
Figure 15. Global ADC Drug CDMO Service Revenue Market Share by Player in 2025
Figure 16. Global ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 18. APAC ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 19. Europe ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa ADC Drug CDMO Service Market Size 2021-2026 ($ millions)
Figure 21. Americas ADC Drug CDMO Service Value Market Share by Country in 2025
Figure 22. United States ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC ADC Drug CDMO Service Market Size Market Share by Region in 2025
Figure 27. APAC ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 29. China ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe ADC Drug CDMO Service Market Size Market Share by Country in 2025
Figure 36. Europe ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa ADC Drug CDMO Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries ADC Drug CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 52. APAC ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 53. Europe ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 55. United States ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. Canada ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. China ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Japan ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Korea ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. India ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Australia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Germany ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. France ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. UK ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Italy ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Russia ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Israel ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Global ADC Drug CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global ADC Drug CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries ADC Drug CDMO Service Market Size 2027-2032 ($ millions)
